You've selected the Pharma/ Biotech Package package


Your details


 
  • Artifical Intelligence
  • Anti-Microbial Resistance/bacterial vaccines
  • Bio-Assays
  • Bioanalytical & Data Assay
  • Cancer Immunotherapy
  • Clinical Development & Trials
  • Clinical Trials
  • Computational
  • Data Management
  • Emerging & Re-Emerging Diseases
  • Immune characterisation/Profiling
  • Immuno Sequencing & Next Generation Sequencing
  • Infectious Diseases
  • Manufacturing & Bioprocessing
  • Market Access
  • Molecular Diagnostics & Biomarkers
  • Monoclonal antibodies
  • New Technology & Discovery
  • Patient Recruitment
  • Platform Technologies
  • Protein Engineering
  • Real World Evidence
  • Regulation and legal
  • Respiratory & Influenza
  • Safety & Pharmacovigilance Other
  • Supply & Logistics
  • Vaccines
  • Veterinary & One Health

    • Please select at least one from:
    [AM1] April 21 (AM) - VACCINE TECHNOLOGY - New vaccine platforms
    [AM3] April 21 (AM) - ALTERNATIVE VACCINE TARGETS
    [AM4] April 21 (AM) - COMBINATION VACCINES
    [AM5] April 21 (AM) - VACCINE MANUFACTURE IN AFRICA
    [PM1] April 21 (PM) - VACCINE DELIVERY
    [PM2] April 21 (PM) - GLOBAL HEALTH - NTDs
    [PM3] April 21 (PM) - HPV ELIMINATION
    [PM4] April 21 (PM) - RSV FOR INFANTS
    [PM5] April 21 (PM) - KOREA'S VACCINE CAPABILITY - KHIDI-RIGHT
    [PM6] April 21 (PM) - Mpox - BAVARIAN NORDIC
    [W1] April 21 (AM & PM) - BIODEFENSE
    [W2] April 21 (AM & PM) - ANTIMICROBIAL RESISTANCE
    [W3] April 21 (AM & PM) - mAbs for INFECTIOUS DISEASES
    OR
    Please select at least one from:
    I am not attending any workshop

    Terrapinn may contact you from time to time with updates and information about our events, products and services that may be of interest. We may also pass your details to carefully selected third parties and to sponsors and exhibitors at this event. Please see our privacy policy for full details.